Jane Street
ENSC icon

Jane Street’s Ensysce Biosciences ENSC Stock Holding History

Jane Street’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.31K Buy
+13,570
New +$8.61K ﹤0.01% 11331
2022
Q4 		– Sell
-6
Closed -$4K – 9367
2022
Q3 		$4K Buy
+6
New +$9.78K ﹤0.01% 9467
2022
Q1 		– Sell
-5
Closed -$79K – 10451
2021
Q4 		$79K Buy
5
+2
+67% +$18.8K ﹤0.01% 9346
2021
Q3 		$38K Buy
+3
New +$58.6K ﹤0.01% 9627

Other funds holding ENSC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's ENSC Position: Q1 2026 in Review

Jane Street opened a new position in Ensysce Biosciences (ENSC) in Q1 2026: 13,570 shares worth $7.31K. The stake represents ﹤0.01% of the portfolio and ranks #11331 among its holdings. This is a return to the name: Jane Street previously reported a position in ENSC as recently as Q3 2022.

Jane Street first reported a position in ENSC in Q3 2021 and has held it in 4 quarters since. The position peaked at $79K in Q4 2021. 15 funds tracked by Wall St. Rank hold ENSC as of Q1 2026.

  • Jane Street held 13,570 shares of Ensysce Biosciences worth $7.31K as of Q1 2026.
  • Ensysce Biosciences was a new Jane Street position in Q1 2026.
  • Ensysce Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11331 holding.
  • Jane Street first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 4 quarters since.
  • Jane Street's Ensysce Biosciences position peaked at $79K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.